Page last updated: 2024-08-17

quinoxalines and Alcoholism

quinoxalines has been researched along with Alcoholism in 18 studies

Research

Studies (18)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (5.56)18.2507
2000's5 (27.78)29.6817
2010's12 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bekker, A; Kang, S; Li, J; Ye, JH1
Abdul-Malak, Y; Ajagbe, TO; Batki, SL; Dimmock, JA; Meszaros, ZS; Wang, D1
Kampman, KM; Lynch, KG; O'Brien, CP; Pettinati, HM; Plebani, JG; Rennert, L1
Anton, RF; Henderson, S; Li, X; Myrick, H; Randall, PK; Schacht, JP1
Brody, A; Courtney, KE; Ghahremani, DG; London, ED; Miotto, K; Ray, LA1
Erwin, BL; Slaton, RM1
Ebert, S; Tetrault, JM1
Higuchi, S; Kimura, M; Maesato, H; Matsushita, S; Mizukami, T; Nakayama, H; Sakuma, H; Takimura, T; Yokoyama, A; Yoneda, J; Yoshimura, A1
Nadeem, SS; Pirmoradi, P; Roshan, S1
Cocores, JA; Gold, MS1
Balchunas, E; Estevez, N; Harrison, EL; Krishnan-Sarin, S; McKee, SA; O'Malley, SS; Petrakis, IL; Picciotto, MR; Shi, J; Tetrault, JM1
Kuehn, BM1
Bartlett, SE; Chatterjee, S1
Croghan, IT; Ebbert, JO; Hays, JT; Hurt, RD; Schroeder, DR1
Bartlett, SE; Fields, HL; Kayser, AS; Mitchell, JM; Teague, CH1
Besheer, J; Cannady, R; Durant, B; Fisher, KR; Hodge, CW1
Gould, TJ; Gulick, D1
Karpukhina, EP; Nikitin, AV; Simvolokov, SI1

Reviews

2 review(s) available for quinoxalines and Alcoholism

ArticleYear
Varenicline in the treatment of alcohol use disorders.
    The Annals of pharmacotherapy, 2014, Volume: 48, Issue:11

    Topics: Alcohol Deterrents; Alcohol Drinking; Alcoholism; Benzazepines; Humans; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Tobacco Use Disorder; Varenicline

2014
Neuronal nicotinic acetylcholine receptors as pharmacotherapeutic targets for the treatment of alcohol use disorders.
    CNS & neurological disorders drug targets, 2010, Volume: 9, Issue:1

    Topics: Alcohol-Induced Disorders, Nervous System; Alcoholism; Animals; Benzazepines; Brain; Humans; Mecamylamine; Neurons; Nicotinic Agonists; Nicotinic Antagonists; Quinoxalines; Receptors, Nicotinic; Tobacco Use Disorder; Varenicline

2010

Trials

7 trial(s) available for quinoxalines and Alcoholism

ArticleYear
Varenicline treatment of concurrent alcohol and nicotine dependence in schizophrenia: a randomized, placebo-controlled pilot trial.
    Journal of clinical psychopharmacology, 2013, Volume: 33, Issue:2

    Topics: Adult; Alcohol Drinking; Alcoholism; Benzazepines; Diagnosis, Dual (Psychiatry); Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotinic Agonists; Pilot Projects; Quinoxalines; Schizophrenia; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome; Varenicline

2013
Results from a pilot clinical trial of varenicline for the treatment of alcohol dependence.
    Drug and alcohol dependence, 2013, Dec-01, Volume: 133, Issue:2

    Topics: Adult; Affect; Alcoholism; Benzazepines; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Pilot Projects; Quinoxalines; Sample Size; Smoking; Socioeconomic Factors; Treatment Outcome; Varenicline

2013
Varenicline effects on drinking, craving and neural reward processing among non-treatment-seeking alcohol-dependent individuals.
    Psychopharmacology, 2014, Volume: 231, Issue:18

    Topics: Adult; Alcohol Drinking; Alcoholism; Benzazepines; Brain; Brain Mapping; Craving; Cues; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Motivation; Nicotinic Agonists; Pilot Projects; Quinoxalines; Reward; Varenicline; Young Adult

2014
Varenicline, naltrexone, and their combination for heavy-drinking smokers: preliminary neuroimaging findings.
    The American journal of drug and alcohol abuse, 2015, Volume: 41, Issue:1

    Topics: Adult; Alcoholism; Benzazepines; Brain; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Treatment Outcome; Varenicline

2015
Varenicline reduces alcohol self-administration in heavy-drinking smokers.
    Biological psychiatry, 2009, Jul-15, Volume: 66, Issue:2

    Topics: Adult; Alcoholism; Benzazepines; Central Nervous System Depressants; Double-Blind Method; Ethanol; Female; Humans; Male; Nicotinic Agonists; Quinoxalines; Smoking; Varenicline; Young Adult

2009
Varenicline for tobacco dependence treatment in recovering alcohol-dependent smokers: an open-label pilot study.
    Journal of substance abuse treatment, 2011, Volume: 40, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Alcoholism; Behavior Therapy; Benzazepines; Comorbidity; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Pilot Projects; Quinoxalines; Smoking Cessation; Temperance; Time Factors; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult

2011
Varenicline decreases alcohol consumption in heavy-drinking smokers.
    Psychopharmacology, 2012, Volume: 223, Issue:3

    Topics: Adult; Alcohol Drinking; Alcoholism; Benzazepines; Double-Blind Method; Drug Administration Schedule; Female; Health Records, Personal; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Treatment Outcome; Varenicline; Young Adult

2012

Other Studies

9 other study(ies) available for quinoxalines and Alcoholism

ArticleYear
Rescue of glutamate transport in the lateral habenula alleviates depression- and anxiety-like behaviors in ethanol-withdrawn rats.
    Neuropharmacology, 2018, Volume: 129

    Topics: Alcoholism; Amino Acid Transport System X-AG; Animals; Antidepressive Agents; Anxiety; Ceftriaxone; Central Nervous System Depressants; Depression; Ethanol; Excitatory Amino Acid Agonists; Excitatory Postsynaptic Potentials; Habenula; In Vitro Techniques; Kainic Acid; Male; Maze Learning; Nerve Tissue Proteins; Quinoxalines; Rats; Rats, Sprague-Dawley; Sodium Channel Blockers; Substance Withdrawal Syndrome; Swimming; Tetrodotoxin

2018
[Varenicline, an optional treatment for alcohol dependence syndrome in smokers or non-smokers].
    Revue medicale suisse, 2014, Oct-08, Volume: 10, Issue:445

    Topics: Alcoholism; Benzazepines; Humans; Multicenter Studies as Topic; Nicotinic Agonists; Pilot Projects; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Varenicline

2014
[Concurrent inpatient smoking cessation and alcohol abstinence programs for alcoholics and their outcomes].
    Nihon Arukoru Yakubutsu Igakkai zasshi = Japanese journal of alcohol studies & drug dependence, 2014, Volume: 49, Issue:6

    Topics: Adult; Aged; Alcohol Abstinence; Alcoholism; Benzazepines; Cognitive Behavioral Therapy; Female; Humans; Inpatients; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome; Varenicline; Young Adult

2014
Neuropsychiatric disturbance after initiation of varenicline in a patient with a history of alcohol abuse and major depression.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2008, Sep-01, Volume: 65, Issue:17

    Topics: Adult; Alcoholism; Benzazepines; Depressive Disorder, Major; Humans; Male; Mental Disorders; Nervous System Diseases; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline

2008
Varenicline, appetite, and weight reduction.
    The Journal of neuropsychiatry and clinical neurosciences, 2008,Fall, Volume: 20, Issue:4

    Topics: Aged; Alcoholism; Benzazepines; Female; Humans; Psychiatric Status Rating Scales; Quinoxalines; Smoking Cessation; Varenicline; Weight Loss

2008
Findings on alcohol dependence point to promising avenues for targeted therapies.
    JAMA, 2009, Apr-22, Volume: 301, Issue:16

    Topics: Alcoholism; Animals; Benzazepines; Humans; Naltrexone; Narcotic Antagonists; Neurokinin-1 Receptor Antagonists; Nicotinic Agonists; Pharmacogenetics; Pyridines; Quinoxalines; Receptors, Corticotropin-Releasing Hormone; Receptors, Opioid, mu; Stress, Psychological; Triazoles; Varenicline

2009
Enhanced AMPA receptor activity increases operant alcohol self-administration and cue-induced reinstatement.
    Addiction biology, 2013, Volume: 18, Issue:1

    Topics: Alcohol Drinking; Alcoholism; Analysis of Variance; Animals; Conditioning, Operant; Cues; Disease Models, Animal; Ethanol; Excitatory Amino Acid Antagonists; Glutamates; Linear Models; Male; Motor Activity; Nootropic Agents; Pyrrolidinones; Quinoxalines; Rats; Receptors, AMPA; Recurrence; Reinforcement, Psychology; Self Administration; Sucrose

2013
Varenicline ameliorates ethanol-induced deficits in learning in C57BL/6 mice.
    Neurobiology of learning and memory, 2008, Volume: 90, Issue:1

    Topics: Acetylcholine; Alcoholism; Animals; Benzazepines; Central Nervous System Depressants; Conditioning, Psychological; Dose-Response Relationship, Drug; Drug Interactions; Ethanol; Freezing Reaction, Cataleptic; Male; Memory Disorders; Mice; Mice, Inbred C57BL; Quinoxalines; Smoking Cessation; Varenicline

2008
[The clinico-immunological efficacy of dioxidine in the combined treatment of acute abscessing pneumonias in persons who abuse alcohol].
    Terapevticheskii arkhiv, 1990, Volume: 62, Issue:1

    Topics: Acute Disease; Adult; Aged; Alcohol Drinking; Alcoholism; Anti-Bacterial Agents; Anti-Infective Agents; Combined Modality Therapy; Drug Evaluation; Female; Humans; Immunity; Lipid Peroxidation; Lung Abscess; Male; Middle Aged; Quinoxalines

1990